BRPI0919176A2 - composição farmacêutica com intensidade iônica relativamente baixa. - Google Patents
composição farmacêutica com intensidade iônica relativamente baixa.Info
- Publication number
- BRPI0919176A2 BRPI0919176A2 BRPI0919176A BRPI0919176A BRPI0919176A2 BR PI0919176 A2 BRPI0919176 A2 BR PI0919176A2 BR PI0919176 A BRPI0919176 A BR PI0919176A BR PI0919176 A BRPI0919176 A BR PI0919176A BR PI0919176 A2 BRPI0919176 A2 BR PI0919176A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- relatively low
- low ionic
- ionic intensity
- intensity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1276—Globules of milk or constituents thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9390008P | 2008-09-03 | 2008-09-03 | |
PCT/US2009/055276 WO2010027907A2 (en) | 2008-09-03 | 2009-08-28 | Pharmaceutical composition having relatively low ionic strength |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0919176A2 true BRPI0919176A2 (pt) | 2015-12-15 |
Family
ID=41231142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0919176A BRPI0919176A2 (pt) | 2008-09-03 | 2009-08-28 | composição farmacêutica com intensidade iônica relativamente baixa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100056537A1 (pt) |
EP (1) | EP2317977B1 (pt) |
JP (2) | JP2012501970A (pt) |
KR (1) | KR20110056398A (pt) |
CN (2) | CN103222951A (pt) |
AR (1) | AR073246A1 (pt) |
AU (1) | AU2009288277B2 (pt) |
BR (1) | BRPI0919176A2 (pt) |
CA (1) | CA2734517A1 (pt) |
MX (1) | MX2011001530A (pt) |
TW (1) | TW201010727A (pt) |
WO (1) | WO2010027907A2 (pt) |
ZA (1) | ZA201100969B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200904485A (en) * | 2007-05-18 | 2009-02-01 | Alcon Res Ltd | Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions |
RU2011130552A (ru) * | 2008-12-22 | 2013-01-27 | Алькон Рисерч, Лтд. | Композиции местных глазных растворов для доставки эффективных концентраций активного агента в задний сегмент глаза |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4407791A (en) * | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
AU1936788A (en) * | 1987-06-01 | 1989-01-04 | Allergan, Inc. | Preservative free ophthalmic ointments |
US4923699A (en) * | 1988-06-03 | 1990-05-08 | Kaufman Herbert E | Eye treatment suspension |
US5286719A (en) * | 1991-10-28 | 1994-02-15 | Mona Industries, Inc. | Phospholipid virucidal compositions |
US5648348A (en) * | 1991-10-28 | 1997-07-15 | Mona Industries, Inc. | Phospholipid antimicrobial compositions |
CN1129400A (zh) * | 1994-05-06 | 1996-08-21 | 阿尔康实验室公司 | 维生素e生育酚衍生物在眼科组合物中的应用 |
US5874469A (en) * | 1996-01-05 | 1999-02-23 | Alcon Laboratories, Inc. | Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs |
US5660858A (en) * | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions |
JP2000505090A (ja) * | 1996-07-11 | 2000-04-25 | ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ | インドール選択的セロトニンアゴニストを含む包接錯体 |
ES2207748T3 (es) * | 1996-08-09 | 2004-06-01 | Alcon Manufacturing Ltd. | Sistemas conservantes para composiciones farmaceuticas que contienen ciclodextrinas. |
US6120758A (en) * | 1998-07-16 | 2000-09-19 | Shaklee Corporation | Preservative system for topically applied products |
CA2342797A1 (en) * | 1998-09-02 | 2000-03-09 | Allergan Sales, Inc. | Preserved cyclodextrin-containing compositions |
AUPP583198A0 (en) * | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
AU2001238552A1 (en) * | 2000-03-17 | 2001-10-03 | Alcon, Inc. | Compounds with 5-HT2 and 5-HT1A agonist activity for treating glaucoma |
US20030207890A1 (en) * | 2001-02-23 | 2003-11-06 | Collier Robert J | Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
CA2428799A1 (en) * | 2000-11-16 | 2002-05-23 | Alcon Manufacturing, Ltd. | Combination therapy for lowering and controlling intraocular pressure |
JP2004262812A (ja) * | 2003-02-28 | 2004-09-24 | Rohto Pharmaceut Co Ltd | 眼圧低下剤 |
DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
US6969706B1 (en) * | 2004-05-12 | 2005-11-29 | Allergan, Inc. | Preserved pharmaceutical compositions comprising cyclodextrins |
AU2005244839B2 (en) * | 2004-05-14 | 2009-12-24 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
JP4642420B2 (ja) * | 2004-09-22 | 2011-03-02 | 博紀 藤田 | コンタクトレンズ取り外し用眼科組成物 |
ZA200704775B (en) * | 2004-12-10 | 2008-08-27 | Alcon Inc | Compositions for treatment of ear infections |
DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
AR062046A1 (es) * | 2006-07-25 | 2008-08-10 | Osmotica Pharmaceutical Argentina S A | Soluciones oftalmicas |
TWI394564B (zh) * | 2006-09-21 | 2013-05-01 | Alcon Res Ltd | 自行保存型水性藥學組成物 |
TW200904485A (en) * | 2007-05-18 | 2009-02-01 | Alcon Res Ltd | Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions |
-
2009
- 2009-08-25 TW TW098128509A patent/TW201010727A/zh unknown
- 2009-08-28 WO PCT/US2009/055276 patent/WO2010027907A2/en active Application Filing
- 2009-08-28 MX MX2011001530A patent/MX2011001530A/es not_active Application Discontinuation
- 2009-08-28 JP JP2011525216A patent/JP2012501970A/ja active Pending
- 2009-08-28 KR KR1020117007455A patent/KR20110056398A/ko not_active Application Discontinuation
- 2009-08-28 CN CN2013101287644A patent/CN103222951A/zh active Pending
- 2009-08-28 EP EP09792023.5A patent/EP2317977B1/en not_active Not-in-force
- 2009-08-28 CA CA2734517A patent/CA2734517A1/en not_active Abandoned
- 2009-08-28 US US12/549,487 patent/US20100056537A1/en not_active Abandoned
- 2009-08-28 CN CN200980134377.3A patent/CN102215819B/zh not_active Expired - Fee Related
- 2009-08-28 BR BRPI0919176A patent/BRPI0919176A2/pt not_active IP Right Cessation
- 2009-08-28 AU AU2009288277A patent/AU2009288277B2/en not_active Ceased
- 2009-08-31 AR ARP090103341A patent/AR073246A1/es not_active Application Discontinuation
-
2011
- 2011-02-07 ZA ZA2011/00969A patent/ZA201100969B/en unknown
-
2014
- 2014-01-27 JP JP2014012601A patent/JP2014074071A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2012501970A (ja) | 2012-01-26 |
WO2010027907A3 (en) | 2011-05-05 |
KR20110056398A (ko) | 2011-05-27 |
CN103222951A (zh) | 2013-07-31 |
ZA201100969B (en) | 2012-05-30 |
EP2317977B1 (en) | 2014-07-23 |
WO2010027907A2 (en) | 2010-03-11 |
CA2734517A1 (en) | 2010-03-11 |
AU2009288277A1 (en) | 2010-03-11 |
AR073246A1 (es) | 2010-10-20 |
EP2317977A2 (en) | 2011-05-11 |
MX2011001530A (es) | 2011-03-25 |
TW201010727A (en) | 2010-03-16 |
US20100056537A1 (en) | 2010-03-04 |
JP2014074071A (ja) | 2014-04-24 |
CN102215819B (zh) | 2014-04-16 |
AU2009288277B2 (en) | 2014-08-21 |
CN102215819A (zh) | 2011-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0812354A2 (pt) | Composição farmacêutica não-aquosa. | |
BRPI0919659A2 (pt) | provisão de sites sugeridos associados com sites-alvos. | |
BRPI0906749A2 (pt) | Composição | |
BRPI0913808A2 (pt) | composição | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI1010301A2 (pt) | composição. | |
BRPI0918122A2 (pt) | molécula de diaboy, diaboy, e mólecula dart | |
BRPI0822830A2 (pt) | Seringa com mecanismo de desativação | |
BRPI0920521A2 (pt) | combinação farmacêutica | |
DE602007009238D1 (de) | Biplanare elektrode mit sperr-gates | |
BRPI0915731A2 (pt) | composição de graxa. | |
BRPI0915732A2 (pt) | composição de graxa. | |
IT1392101B1 (it) | Composizione comprendente isoflavoni | |
BRPI0905369A2 (pt) | Composição farmacêutica, composição e kit compartimentado | |
BRPI0917231A2 (pt) | composição | |
BRPI0910605A2 (pt) | Composição com sensação de aquecimento | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0917446A2 (pt) | derivados de acilaminobenzamida. | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
BRPI1010609A2 (pt) | composições de cura de umidade com intensidade inicial aprimorada. | |
BRPI0906714A2 (pt) | Derivados de oxazepinopirimidona heteroarilamida substituídos. | |
BRPI0912171A2 (pt) | composição farmacêutica | |
BRPI0922286A2 (pt) | composto de quinolona e composição farmacêutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |